Thuja Capital
Thuja Capital invests in early stage medical product innovations
Business Model:
Revenue: $7.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Thuja Capital Information
Geographic Data
Address: Yalelaan 40
City: Utrecht
State: utrecht
Zip: 3584
Country: NL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
6,195,185Website Global Rank
1,121Website Monthly Traffic
Twitter Followers
Description
Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2010 | arGEN-X | Series A | 4.5M |
| 4/2007 | Curacyte AG | Venture Round | - |
| 1/2015 | Hemics | Series B | - |
| 8/2011 | TheraSolve | Venture Round | - |
| 11/2014 | EnCare Biotech | Series A | 5.5M |
| 11/2008 | Okapi Sciences | Series A | 0 |
| 3/2022 | InnoSIGN | Series A | 8.1M |
| 10/2016 | MILabs | Venture Round | - |
| 8/2020 | NutriLeads | Series B | 0 |
| 11/2022 | FundaMental Pharma | Seed Round | 10.4M |
| 3/2017 | NutriLeads | Series A | - |
| 1/2019 | Salvia BioElectronics | Seed Round | 2.1M |
| 10/2021 | Alveron Pharma | Seed Round | 0 |
| 12/2021 | ATRO Medical | Venture Round | 0 |
| 11/2015 | NutriLeads | Seed Round | - |
| 1/2008 | Cavadis | Venture Round | - |
| 9/2011 | Hemics | Series A | - |
| 12/2014 | Cristal Therapeutics | Venture Round | 7.5M |
| 8/2017 | Mellon Medical | Series B | 7.1M |
| 5/2018 | Salvia BioElectronics | Seed Round | 1.5M |
| 12/2016 | Indigo Diabetes | Series A | 0 |
| 8/2007 | Enanta Pharmaceuticals | Venture Round | - |
| 7/2017 | ATRO Medical | Series A | - |
| 2/2007 | Omrix Biopharmaceuticals | Post-IPO Equity | - |
| 2/2007 | Coley Pharmaceutical Group | Post-IPO Equity | - |
| 1/2007 | Vernalis | Venture Round | - |
| 1/2007 | Avantium | Venture Round | - |
| 3/2007 | Breonics | Venture Round | - |
| 8/2022 | AstriVax | Seed Round | 30M |
| 8/2007 | EpiCept Corporation | Venture Round | - |
| 7/2020 | Indigo Diabetes | Series B | 0 |
| 6/2007 | Develogen AG | Venture Round | - |
| 8/2007 | Galapagos | Venture Round | - |
| 4/2011 | Nightbalance | Seed Round | - |
| 9/2007 | Okapi Sciences | Venture Round | - |
| 12/2007 | Intercell | Post-IPO Equity | - |
| 7/2013 | Nightbalance | Series A | - |
| 7/2007 | Drug Abuse Sciences | Venture Round | - |
| 6/2007 | Ingenium Pharmaceuticals AG | Venture Round | - |
| 5/2013 | Mellon Medical | Venture Round | - |
| 12/2021 | Synerkine Pharma | Series A | 4M |
| 3/2019 | Synerkine Pharma | Series A | 3.7M |
| 1/2008 | Bioceros | Venture Round | - |
| 7/2016 | Nightbalance | Series B | 0 |
| 3/2009 | DCPrime | Venture Round | - |
| 9/2020 | Salvia BioElectronics | Series A | 0 |
| 1/2010 | FABPulous | Series A | - |
| 2/2015 | FABPulous | Series B | 0 |
| 5/2009 | Cavadis | Series A | - |
| 3/2022 | InnoSIGN | Series A | 0 |
| 12/2021 | Synerkine Pharma | Series A | 0 |
| 12/2021 | ATRO Medical | Venture Round | 0 |
| 10/2021 | Alveron Pharma | Seed Round | 0 |
| 9/2020 | Salvia BioElectronics | Series A | 0 |
| 8/2020 | NutriLeads | Series B | 0 |
| 7/2020 | Indigo Diabetes | Series B | 0 |
| 3/2019 | Synerkine Pharma | Series A | 0 |
| 1/2019 | Salvia BioElectronics | Seed Round | 0 |
| 5/2018 | Salvia BioElectronics | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
